Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

CMV infection increases the risk of GvHD after bone marrow transplants.

Indinavir and ritonavir therapy can cause reversible hair loss.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The vector successfully directed specific gene expression in hair follicles.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

HHV-6 reactivation may be linked to psychiatric disorders and can improve with antiviral treatment.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Effective delivery of gene editors is crucial for safe and successful gene editing in healthcare and agriculture.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

A new delivery system makes Curcumin more effective and safer against viruses.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.